Pediatric Drug Hypersensitivity
- PMID: 30793223
- DOI: 10.1007/s11882-019-0841-y
Pediatric Drug Hypersensitivity
Abstract
Purpose of review: Pediatric drug hypersensitivity is a rapidly evolving field. The purpose of this paper is to review the current state of pediatric drug hypersensitivity and highlight new developments in diagnosis and management.
Recent findings: This paper will discuss the safety and use of risk stratification to proceed directly to oral challenge without prior skin testing for β-lactam reactions. We review unique aspects of pediatric drug challenges and desensitizations. It is important to accurately diagnose pediatric drug hypersensitivity reactions through a detailed history, physical examination, and available diagnostic testing. Understanding of the underlying mechanism leads to appropriate classification which is necessary to direct management. The decision to perform drug challenge, desensitization, or recommend avoidance of a medication can have a significant impact on a patient's treatment. Utilization of weight-based dose and infusion rate adjustments for current drug challenge and desensitization protocols optimize success.
Keywords: Desensitization; Drug allergy; Drug challenge; Drug hypersensitivity; Medication allergy; Pediatric.
Similar articles
-
Desensitization in patients with beta-lactam drug allergy.Allergol Immunopathol (Madr). 2013 Sep-Oct;41(5):298-303. doi: 10.1016/j.aller.2012.06.003. Epub 2012 Nov 21. Allergol Immunopathol (Madr). 2013. PMID: 23177979
-
Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1564-1571. doi: 10.1016/j.jaip.2017.08.004. J Allergy Clin Immunol Pract. 2017. PMID: 29122155
-
Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):40-5. doi: 10.1016/j.jaip.2013.08.011. Epub 2013 Nov 1. J Allergy Clin Immunol Pract. 2014. PMID: 24565767
-
Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.Allergy. 2013 Jul;68(7):844-52. doi: 10.1111/all.12161. Epub 2013 Jun 7. Allergy. 2013. PMID: 23745779 Review.
-
Management of adverse reactions induced by chemotherapy drugs.Curr Opin Allergy Clin Immunol. 2022 Aug 1;22(4):221-225. doi: 10.1097/ACI.0000000000000833. Curr Opin Allergy Clin Immunol. 2022. PMID: 35852896 Review.
Cited by
-
Don't we overestimate drug allergies in children?Int J Occup Med Environ Health. 2023 Nov 27;36(5):632-642. doi: 10.13075/ijomeh.1896.02227. Epub 2023 Sep 25. Int J Occup Med Environ Health. 2023. PMID: 37750429 Free PMC article.
-
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.World Allergy Organ J. 2022 May 31;15(6):100640. doi: 10.1016/j.waojou.2022.100640. eCollection 2022 Jun. World Allergy Organ J. 2022. PMID: 35694005 Free PMC article. Review.
-
Allergy to penicillin and betalactam antibiotics.Einstein (Sao Paulo). 2021 Apr 26;19:eMD5703. doi: 10.31744/einstein_journal/2021MD5703. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 33909756 Free PMC article.
-
Mining Severe Drug Hypersensitivity Reaction Cases in Pediatric Electronic Health Records: Methodology Development and Applications.JMIR Med Inform. 2022 Sep 13;10(9):e37812. doi: 10.2196/37812. JMIR Med Inform. 2022. PMID: 36099001 Free PMC article.
-
Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes.Allergy. 2025 Jan;80(1):271-286. doi: 10.1111/all.16296. Epub 2024 Aug 31. Allergy. 2025. PMID: 39215539 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials